Gainesville, FL, United States of America

Jeffrey R Sirninger

This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, University of Florida Research Foundation Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey R Sirninger. Retrieved from https://idiyas.com/inventor/jeffrey-r-sirninger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeffrey R. Sirninger: Inventor in Cystic Fibrosis Gene Therapy.

Introduction

Jeffrey R. Sirninger is an inventor associated with Gainesville, Florida, and research in gene therapy for cystic fibrosis. His work includes an invention involving adeno-associated virus (AAV) vectors and constructs intended to deliver gene therapy to people with the condition.

Latest Patents

Sirninger is listed as an inventor on 1 patent: “Compositions for Treating Cystic Fibrosis.” The patent describes compositions and methods for treating cystic fibrosis, including the use of AAV vectors and constructs to provide gene therapy.

Career Highlights

Sirninger’s listed affiliations include the University of Florida Research Foundation, Inc., and Johns Hopkins University. These institutions are associated with research and development in biomedical science and technology.

Collaborations

His listed collaborators include Liudmila Cebotaru and Terence R. Flotte. Their shared work is connected to research on gene-based approaches to cystic fibrosis treatment.

Conclusion

Jeffrey R. Sirninger’s patent work focuses on applying AAV-based gene therapy to cystic fibrosis, reflecting a research effort aimed at developing new treatment approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…